1.
The potential of proteins, hydrolysates and peptides as growth factors for Lactobacillus and Bifidobacterium: current research and future perspectives.
Zhang, C, Zhang, Y, Li, H, Liu, X
Food & function. 2020;(3):1946-1957
Abstract
Probiotics are live microorganisms that provide health benefits to the host when consumed in adequate concentrations. The strains most frequently used as probiotics include Lactobacillus and Bifidobacteria. Probiotics have demonstrated significant potential as therapeutic options for various diseases. In addition to oligosaccharides, proteins, hydrolysates and peptides have also been shown function as prebiotics to promote the growth of probiotics. Therefore, this review provides a summary of the available information and current knowledge on the effects of various proteins on probiotics, focusing on how proteins influence probiotics, although uncertainties and disagreements about how the metabolism of proteins promotes probiotics still exist. Understanding the relationship between proteins and probiotics will allow appropriate prebiotic selection and the development of effective methods to promote the proliferation of probiotics.
2.
Fructooligosaccharide (FOS) and Galactooligosaccharide (GOS) Increase Bifidobacterium but Reduce Butyrate Producing Bacteria with Adverse Glycemic Metabolism in healthy young population.
Liu, F, Li, P, Chen, M, Luo, Y, Prabhakar, M, Zheng, H, He, Y, Qi, Q, Long, H, Zhang, Y, et al
Scientific reports. 2017;(1):11789
Abstract
The gut microbiota has been implicated in glucose intolerance and its progression towards type-2 diabetes mellitus (T2DM). Relevant randomized clinical trial with prebiotic intervention was inadequate. We sought to evaluate the impact of fructooligosaccharides (FOS) and galactooligosaccharides (GOS) on glycemia during oral glucose tolerance test (OGTT) and intestinal microbiota. A randomized double-blind cross-over study was performed with 35 adults treated with FOS and GOS for 14 days (16 g/day). Faeces sampling, OGTT and anthropometric parameters were performed. Short-term intake of high-dose prebiotics had adverse effect on glucose metabolism, as in FOS intervention demonstrated by OGTT (P < 0.001), and in GOS intervention demonstrated by fasting glucose (P < 0.05). A significant increase in the relative abundance of Bifidobacterium was observed both in FOS and GOS group, while the butyrate-producing bacteria like Phascolarctobacterium in FOS group and Ruminococcus in GOS group were decreased. A random forest model using the initial microbiota was developed to predict OGTT levels after prebiotic intervention with relative success (R = 0.726). Our study alerted even though FOS and GOS increased Bifidobacterium, they might have adverse effect on glucose metabolism by reducing butyrate-producing microbes. Individualized prebiotics intervention based on gut microbiome needs to be evaluated in future.